Drugs / NVP-1805-R2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT05354713 Comparator | Nov 2022 → Mar 2023 | — | NVP Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT04905342 Comparator | Aug → Dec 2021 | — | NVP Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT04780386 Comparator | Aug → Nov 2020 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1805-R2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04780386 ↗ |
| Route | Oral | “orally, once daily on Period 1 or Period 3 (or Period 2 and Period 4)” NCT04780386 ↗ |